TARA icon

Protara Therapeutics

59 hedge funds and large institutions have $124M invested in Protara Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

8.24% less ownership

Funds ownership: 86.45%78.22% (-8.2%)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

21% less capital invested

Capital invested by funds: $157M → $124M (-$32.8M)

Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.21M
Puts
$478K
Net Calls
Net Calls Change

Top Buyers

1 +$6.96M
2 +$3.66M
3 +$2.19M
4
UBS Group
UBS Group
Switzerland
+$2.08M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.04M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$849K
27
$795K
28
$647K
29
$623K
30
$551K
31
$523K
32
$397K
33
$390K
34
$354K
35
$320K
36
$307K
37
$297K
38
$282K
39
$264K
40
$234K
41
$170K
42
$170K
43
$154K
44
$127K
45
$100K
46
$98K
47
$81.8K
48
$79.7K
49
$78.2K
50
$63.9K